Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring.
Journal: Ophthalmology
Published: February 14, 2017
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: June 30, 2016
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
Journal: Cornea
Published: April 08, 2016
Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
Journal: Ophthalmology
Published: December 22, 2015
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Journal: Ophthalmology
Published: May 21, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026